[HTML][HTML] Adalimumab with or without methotrexate in juvenile rheumatoid arthritis

…, N Ruperto, S Goodman, A Reiff, L Jung… - … England Journal of …, 2008 - Mass Medical Soc
Background Tumor necrosis factor (TNF) has a pathogenic role in juvenile rheumatoid
arthritis. We evaluated the efficacy and safety of adalimumab, a fully human monoclonal anti-TNF …

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

…, M Fischbach, J Orozco, PJ Hashkes, C Hom, L Jung… - The Lancet, 2008 - thelancet.com
Background Some children with juvenile idiopathic arthritis either do not respond, or are
intolerant to, treatment with disease-modifying antirheumatic drugs, including anti-tumour …

[HTML][HTML] Leflunomide or methotrexate for juvenile rheumatoid arthritis

E Silverman, R Mouy, L Spiegel, LK Jung… - New England journal …, 2005 - Mass Medical Soc
Background We compared the safety and efficacy of leflunomide with that of methotrexate in
the treatment of polyarticular juvenile rheumatoid arthritis in a multinational, randomized, …

Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus

…, AO Hersh, R Hollister, O Jones, L Jung… - Arthritis care & …, 2012 - Wiley Online Library
Objective To formulate consensus treatment plans (CTPs) for induction therapy of newly
diagnosed proliferative lupus nephritis (LN) in juvenile systemic lupus erythematosus (SLE). …

[HTML][HTML] Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition

…, L Zou, J Wu, L Guo, L Teng, R Zheng, LKL Jung… - Pediatric …, 2019 - Springer
Background As an acute febrile and inflammatory disease, Kawasaki disease (KD) could
develop Kawasaki disease shock syndrome (KDSS) sometimes. However its pathogenesis …

Comparing presenting clinical features in 48 children with microscopic polyangiitis to 183 children who have granulomatosis with polyangiitis (Wegener's): an …

…, E Cassidy, K Torok, M Becker, LK Jung… - Arthritis & …, 2016 - Wiley Online Library
Objective To uniquely classify children with microscopic polyangiitis (MPA), to describe their
demographic characteristics, presenting clinical features, and initial treatments in …

Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima‐media thickness in the Atherosclerosis Prevention in …

…, GC Higgins, HI Brunner, L Jung… - Arthritis & …, 2009 - Wiley Online Library
Objective To evaluate risk factors for subclinical atherosclerosis in a population of patients
with pediatric systemic lupus erythematosus (SLE). Methods In a prospective multicenter study…

Association of Anti–3‐Hydroxy‐3‐Methylglutaryl‐Coenzyme A Reductase Autoantibodies With DRB1* 07: 01 and Severe Myositis in Juvenile Myositis Patients

…, CR Johnson, OY Jones, LK Jung… - Arthritis care & …, 2017 - Wiley Online Library
Objective Autoantibodies recognizing 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase (HMGCR)
are associated with statin exposure, the HLA allele DRB1*11:01, and necrotizing …

Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib

…, SJ Hwang, HS Kuehn, H Kim, L Jung… - Brain, 2019 - academic.oup.com
Sir, The recent article by Ladislau et al. on the pathogenicity of type I interferon (IFN) and the
effect of type I IFN pathway blockade in vitro was received with great interest. Increasing …

Development of a novel renal activity index of lupus nephritis in children and young adults

…, NG Singer, B Anne Eberhard, LK Jung… - Arthritis care & …, 2016 - Wiley Online Library
Objective Noninvasive estimation of the degree of inflammation seen on kidney biopsy with
lupus nephritis (LN) remains difficult. The objective of this study was to develop a Renal …